Cargando…

Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial

BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related event...

Descripción completa

Detalles Bibliográficos
Autores principales: Rief, Harald, Omlor, Georg, Akbar, Michael, Bruckner, Thomas, Rieken, Stefan, Förster, Robert, Schlampp, Ingmar, Welzel, Thomas, Bostel, Tilman, Roth, Heinz Jürgen, Debus, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794897/
https://www.ncbi.nlm.nih.gov/pubmed/26983672
http://dx.doi.org/10.1186/s12885-016-2278-1
_version_ 1782421545076916224
author Rief, Harald
Omlor, Georg
Akbar, Michael
Bruckner, Thomas
Rieken, Stefan
Förster, Robert
Schlampp, Ingmar
Welzel, Thomas
Bostel, Tilman
Roth, Heinz Jürgen
Debus, Jürgen
author_facet Rief, Harald
Omlor, Georg
Akbar, Michael
Bruckner, Thomas
Rieken, Stefan
Förster, Robert
Schlampp, Ingmar
Welzel, Thomas
Bostel, Tilman
Roth, Heinz Jürgen
Debus, Jürgen
author_sort Rief, Harald
collection PubMed
description BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related events (SRE), and number of metastases. METHODS: In this randomized trial, 60 patients were allocated from September 2011 to March 2013 into one of the two arms: resistance training (Arm A) or passive physical therapy (Arm B) with thirty patients in each arm during RT. Biochemical markers such as pyridinoline (PYD), desoxy-pyridinoline (DPD), bone alkaline phosphatase (BAP), total amino-terminal propeptide of type I collagen (PINP), beta-isomer of carboxy-terminal telopeptide of type I collagen (CTX-I), and cross-linked N-telopeptide of type I collagen (NTX) were analyzed at baseline, and three months after RT. RESULTS: Mean change values of PYD and CTX-I were significantly lower at 3 months after RT (p = 0.035 and p = 0.043) in Arm A. Importantly, all markers decreased in both arms, except of PYD and CTX-I in arm B, although significance was not reached for some biomarkers. In arm A, the local response was significantly higher (p = 0.003) and PINP could be identified as a predictor for survivors (OR 0.968, 95%CI 0.938–0.999, p = 0.043). BAP (OR 0.974, 95%CI 0.950–0.998, p = 0.034) and PINP (OR 1.025, 95%CI 1.001–1.049, p = 0.044) were related with an avoidance of SRE. CONCLUSIONS: In this group of patients with spinal bone metastases, we were able to show that patients with guided resistance training of the paravertebral muscles can influence BTM. PYD and CTX-I decreased significantly in arm A. PINP can be considered as a complementary tool for prediction of local response, and PINP as well as BAP for avoidance of SRE. TRIAL REGISTRATION: Clinical trial identifier NCT 01409720. August 2, 2011.
format Online
Article
Text
id pubmed-4794897
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47948972016-03-17 Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial Rief, Harald Omlor, Georg Akbar, Michael Bruckner, Thomas Rieken, Stefan Förster, Robert Schlampp, Ingmar Welzel, Thomas Bostel, Tilman Roth, Heinz Jürgen Debus, Jürgen BMC Cancer Research Article BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related events (SRE), and number of metastases. METHODS: In this randomized trial, 60 patients were allocated from September 2011 to March 2013 into one of the two arms: resistance training (Arm A) or passive physical therapy (Arm B) with thirty patients in each arm during RT. Biochemical markers such as pyridinoline (PYD), desoxy-pyridinoline (DPD), bone alkaline phosphatase (BAP), total amino-terminal propeptide of type I collagen (PINP), beta-isomer of carboxy-terminal telopeptide of type I collagen (CTX-I), and cross-linked N-telopeptide of type I collagen (NTX) were analyzed at baseline, and three months after RT. RESULTS: Mean change values of PYD and CTX-I were significantly lower at 3 months after RT (p = 0.035 and p = 0.043) in Arm A. Importantly, all markers decreased in both arms, except of PYD and CTX-I in arm B, although significance was not reached for some biomarkers. In arm A, the local response was significantly higher (p = 0.003) and PINP could be identified as a predictor for survivors (OR 0.968, 95%CI 0.938–0.999, p = 0.043). BAP (OR 0.974, 95%CI 0.950–0.998, p = 0.034) and PINP (OR 1.025, 95%CI 1.001–1.049, p = 0.044) were related with an avoidance of SRE. CONCLUSIONS: In this group of patients with spinal bone metastases, we were able to show that patients with guided resistance training of the paravertebral muscles can influence BTM. PYD and CTX-I decreased significantly in arm A. PINP can be considered as a complementary tool for prediction of local response, and PINP as well as BAP for avoidance of SRE. TRIAL REGISTRATION: Clinical trial identifier NCT 01409720. August 2, 2011. BioMed Central 2016-03-17 /pmc/articles/PMC4794897/ /pubmed/26983672 http://dx.doi.org/10.1186/s12885-016-2278-1 Text en © Rief et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rief, Harald
Omlor, Georg
Akbar, Michael
Bruckner, Thomas
Rieken, Stefan
Förster, Robert
Schlampp, Ingmar
Welzel, Thomas
Bostel, Tilman
Roth, Heinz Jürgen
Debus, Jürgen
Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title_full Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title_fullStr Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title_full_unstemmed Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title_short Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
title_sort biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794897/
https://www.ncbi.nlm.nih.gov/pubmed/26983672
http://dx.doi.org/10.1186/s12885-016-2278-1
work_keys_str_mv AT riefharald biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT omlorgeorg biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT akbarmichael biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT brucknerthomas biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT riekenstefan biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT forsterrobert biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT schlamppingmar biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT welzelthomas biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT bosteltilman biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT rothheinzjurgen biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial
AT debusjurgen biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial